Research Monday:
Menopause Is More Than Hot Flashes — What Happens to Muscle & Bone?
We talk about hot flashes, periods stopping and mood changes when we talk about menopause.
But while I was researching this week, I kept coming back to a different question:
Why aren’t we talking to women earlier about what can happen to their muscle, strength and bones?
And then I found something that surprised me even more.
We actually don’t have nearly as much high-quality exercise research during the menopause transition as I assumed we did.
Perimenopause isn’t simply estrogen slowly sliding downward in a perfectly straight line. Hormonal patterns fluctuate through the transition, and the menopause transition overlaps with an age when changes in body composition, muscle and bone are already occurring.
Bone deserves particular attention because estrogen has an important role in regulating bone remodeling. Around menopause, bone resorption can outpace formation.
Muscle is a little more complicated.
Menopause, aging, physical activity, nutrition and other factors overlap, which makes it difficult to say:
“This amount of muscle loss happened specifically because estrogen declined.”
That’s an important distinction.
WHY does this matter?
Think about your body like a retirement account.
You don’t wait until retirement to start saving.
Muscle, strength and bone are similar.
What you build and preserve in your 40s and 50s affects the physical reserve you’re carrying into your 60s, 70s and 80s.
We’re not training simply because we want our arms to look good.
We’re building the ability to:
get off the floor, carry groceries, climb stairs, catch ourselves when we trip, tolerate a fall better, maintain independence and keep doing the things we actually enjoy.
That’s a completely different reason to lift.
The research gap I wasn’t expecting
A 2025 systematic review asked a very specific question:
Can exercise prevent bone and muscle loss during peri- and early postmenopause?
Researchers searched five major databases for randomized controlled trials involving women ages 45–60 who were perimenopausal or early postmenopausal.
Guess how many studies qualified?
SIX.
Two studied perimenopausal women.
Four studied women in early postmenopause.
And the authors rated the overall evidence low quality with high risk of bias.
That’s important.
It does not mean:
“Exercise doesn’t work during perimenopause.”
It means:
We don’t have enough good trials specifically studying women during this transition to confidently determine the optimal training method for preventing muscle and bone loss.
Those are completely different statements.
Evidence tier: 🟡 LIMITED
Population: women 45–60 in peri-/early postmenopause
Studies: 6 RCTs
Major limitation: tiny evidence base + heterogeneous exercise protocols + high risk of bias
Conclusion: We cannot yet identify an optimal menopause-transition exercise prescription.
And THIS is why I keep telling you:
Don’t only ask,
“What did the study find?”
Ask:
“Who did they actually study?”
SO WHAT happens when we look at women AFTER menopause?
Now the evidence gets considerably larger.
A 2025 systematic review/meta-analysis included 17 randomized trials and 690 postmenopausal women.
Resistance training improved bone mineral density at the lumbar spine, femoral neck and total hip.
But there’s an important limitation: results differed substantially between studies for the lumbar spine and femoral neck, meaning we shouldn’t pretend every resistance program produces the same result.
Another 2025 meta-analysis included 40 studies and 2,230 postmenopausal women ages 50–60 and reported improvements in BMD across several skeletal sites with aerobic, resistance and combined exercise interventions.
And a newly published 2026 analysis of high-intensity, impact and strength training found small improvements in femoral-neck and lumbar-spine BMD in postmenopausal women—but again emphasized the small number of trials and methodological limitations.
Evidence tier: 🟢 MODERATE / CONSISTENT DIRECTION
Resistance and appropriately prescribed weight-bearing/impact exercise are legitimate tools for maintaining musculoskeletal health after menopause.
What we cannot say is:
“Here’s the single perfect menopause workout.”
That evidence doesn’t exist.
WHAT NOW? Here’s the solution layer.
This is the part of Research Monday I never want us skipping.
If declining muscle, strength and bone are the concern…
what can women actually DO?
1. Resistance training becomes incredibly valuable.
The evidence in postmenopausal women consistently supports resistance training for muscular strength and function, with growing evidence for bone benefits as well.
Interestingly, a 2025 Journal of Strength and Conditioning Research review found 69 studies of resistance programs in postmenopausal women.
Most used full-body programs.
Common prescriptions included roughly:
3 × 8
or
3 × 10
with intensity frequently around 80% 1RM or an 8RM load.
That doesn’t mean every menopausal woman should immediately train at 80% 1RM.
It tells us what researchers have commonly tested.
The right program still depends on training history, osteoporosis/fracture status, injuries and ability.
2. Don’t forget impact and weight-bearing activity.
Bone responds to mechanical loading.
A new 2026 meta-analysis pooling high-intensity, impact and strength interventions found small but significant improvements in lumbar-spine and femoral-neck BMD among postmenopausal women.
But impact exercise isn’t appropriate for every woman—particularly without modification when osteoporosis, fracture history, significant joint disease or other limitations are present.
So:
progressive loading > randomly jumping because TikTok said jumping builds bones.
🧪 Supplement Spotlight: CREATINE
This one got considerably more interesting this year.
A 2026 systematic review and meta-analysis examined 7 randomized placebo-controlled trials involving 608 postmenopausal women, average age around 62.
Creatine produced a small increase in lean mass:
+0.37 kg
and improved leg-press strength:
+7.5 kg.
Benefits appeared stronger when ≥5 g/day was combined with resistance training.
But here’s the part supplement marketing will probably leave out:
Creatine did NOT significantly improve bone mineral density overall.
So I’m not going to tell women:
“Take creatine to prevent osteoporosis.”
That’s ahead of the evidence.
A better interpretation is:
🟢 Creatine + resistance training: promising evidence for lean mass/strength.
⚪ Creatine for BMD: not established.
Adverse events were similar to placebo and renal markers were unchanged in these trials, although individual medical circumstances still matter.
That’s how we’re going to discuss supplements here.
Not: “Does it work?”
But:
“What outcome does it work FOR?”
🧬 PEPTIDE / EMERGING THERAPY SPOTLIGHT
Now THIS is interesting.
Researchers are investigating myostatin (GDF8) and activin A, signaling proteins that act partly like biological brakes on muscle growth.
A 2025 randomized Phase I trial published in Nature Communications tested antibodies blocking these pathways.
And here’s why it belongs in today’s discussion:
The human participants included healthy postmenopausal women.
The study enrolled 82 participants overall, with the trial conducted at two sites in New Zealand.
Blocking both GDF8 and activin A increased muscle volume more than blocking either pathway alone, and increases in muscle were accompanied by reductions in fat.
Sounds incredible.
But stop right there.
🔴 This is NOT a menopause treatment recommendation.
This was Phase I research.
The primary purpose was safety/tolerability—not proving that healthy menopausal women should use muscle-building biologics.
The study was also heavily industry-associated: many authors were affiliated with Regeneron⁠.
That’s not a reason to dismiss the research.
It is a reason to remember why funding, conflicts and replication matter.
Evidence tier: 🟠 EARLY HUMAN / HYPOTHESIS-GENERATING
What would move my confidence higher?
Larger independent Phase II/III trials demonstrating not merely increased muscle volume, but meaningful improvements in strength, function, safety and long-term outcomes.
Until then:
fascinating science ≠ clinical recommendation.
GLOBAL CONTEXT
The evidence isn’t exclusively American.
The menopause-transition review synthesized international literature. The GDF8/activin trial included research sites in New Zealand. Other recent menopause exercise analyses include studies from multiple regions, and the newest International Menopause Society recommendations were produced by an international writing group of 38 authors covering lifestyle, bone, cardiometabolic health, sexual health and other aspects of midlife health.
But there’s still a major representation problem.
Exercise studies frequently lump women into broad categories like “postmenopausal.”
That’s not the same thing as specifically studying:
early perimenopause → late perimenopause → early postmenopause → later postmenopause.
That’s precisely why the six-trial finding matters.
MYTH CHECK
❌ “Menopause automatically destroys your body.”
No.
Aging and the menopause transition affect musculoskeletal health, but women retain substantial ability to adapt to training.
❌ “Scientists already know the perfect menopause workout.”
Definitely not.
❌ “Cardio is enough.”
Cardiovascular exercise matters enormously, but it doesn’t make progressive resistance training irrelevant.
❌ “Creatine prevents menopausal bone loss.”
Current pooled evidence doesn’t establish that.
❌ “Experimental muscle-building therapies are basically the next menopause peptide stack.”
Absolutely not.
Early human biological plausibility isn’t a prescription.
My confidence
Resistance training improves strength/function after menopause: 9/10
Resistance training can benefit postmenopausal BMD: 8/10
Exactly how women should train specifically during perimenopause: 5/10
Not because exercise suddenly stops working.
Because we haven’t studied that population well enough.
Creatine + resistance training for postmenopausal lean mass/strength: 7/10
Creatine specifically for improving BMD: 3/10
GDF8/activin blockade as a future muscle therapy: 2/10 clinically, 7/10 as an interesting research direction.
One-minute version
Here’s what I want you remembering:
Menopause isn’t a deadline on strength.
Women can still build strength and respond to resistance training after menopause.
Bone remains responsive to mechanical loading.
Creatine may provide a modest additional benefit for muscle/strength when paired with resistance training.
But the uncomfortable research truth is that the exact period when women are moving through perimenopause remains dramatically understudied.
So I don’t want us saying:
“Here’s the perfect menopause protocol.”
I want us saying:
“Here’s what we know, here’s what we’re borrowing from stronger evidence in postmenopausal women, and here’s what scientists still need to test.”
That’s much more useful.
0
0 comments
Bobbie Whitehead
3
Research Monday:
powered by
GOATGETheR
skool.com/goatgether-3744
Evidence-based women’s health, fitness & performance. Research simplified. Build confidence, strength & become a founding member.
Build your own community
Bring people together around your passion and get paid.
Powered by